BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28110245)

  • 1. Bipartite network analysis reveals metabolic gene expression profiles that are highly associated with the clinical outcomes of acute myeloid leukemia.
    Xie F; He M; He L; Liu K; Li M; Hu G; Wen Z
    Comput Biol Chem; 2017 Apr; 67():150-157. PubMed ID: 28110245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network-based sub-network signatures unveil the potential for acute myeloid leukemia therapy.
    Shi M; Wu M; Pan P; Zhao R
    Mol Biosyst; 2014 Dec; 10(12):3290-7. PubMed ID: 25313005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
    Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM
    BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated module approach identifies disrupted genes and pathways associated with acute myelocytic leukemia.
    Fang Y; Xie LN; Liu XM; Yu Z; Kong FS; Song NX; Zhou F
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4811-26. PubMed ID: 26744873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes.
    Zhao X; Li Y; Wu H
    Int J Mol Med; 2018 Sep; 42(3):1495-1507. PubMed ID: 29956722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
    Luo H; Qin Y; Reu F; Ye S; Dai Y; Huang J; Wang F; Zhang D; Pan L; Zhu H; Wu Y; Niu T; Xiao Z; Zheng Y; Liu T
    J Hematol Oncol; 2016 Nov; 9(1):125. PubMed ID: 27855695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions.
    Seiler K; Humbert M; Minder P; Mashimo I; Schläfli AM; Krauer D; Federzoni EA; Vu B; Moresco JJ; Yates JR; Sadowski MC; Radpour R; Kaufmann T; Sarry JE; Dengjel J; Tschan MP; Torbett BE
    Cell Death Dis; 2022 May; 13(5):448. PubMed ID: 35538058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic genes in the acute myeloid leukemia microenvironment.
    Huang S; Zhang B; Fan W; Zhao Q; Yang L; Xin W; Fu D
    Aging (Albany NY); 2019 Nov; 11(22):10557-10580. PubMed ID: 31740623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
    Rao AV; Valk PJ; Metzeler KH; Acharya CR; Tuchman SA; Stevenson MM; Rizzieri DA; Delwel R; Buske C; Bohlander SK; Potti A; Löwenberg B
    J Clin Oncol; 2009 Nov; 27(33):5580-6. PubMed ID: 19858393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
    Yan H; Wen L; Tan D; Xie P; Pang FM; Zhou HH; Zhang W; Liu ZQ; Tang J; Li X; Chen XP
    Oncotarget; 2017 Jan; 8(1):1529-1540. PubMed ID: 27903973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
    Chang H; Gao Q; Ding W; Qing X
    PLoS One; 2018; 13(3):e0194245. PubMed ID: 29570744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
    de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
    Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival prediction in acute myeloid leukemia using gene expression profiling.
    Lai B; Lai Y; Zhang Y; Zhou M; OuYang G
    BMC Med Inform Decis Mak; 2022 Mar; 22(1):57. PubMed ID: 35241089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications.
    Foroushani A; Agrahari R; Docking R; Chang L; Duns G; Hudoba M; Karsan A; Zare H
    BMC Med Genomics; 2017 Mar; 10(1):16. PubMed ID: 28298217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
    Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
    J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia.
    Yin X; Lyu C; Li Z; Wang Q; Ding Y; Wang Y; Qiu Y; Cui S; Guo D; Xu R
    J Healthc Eng; 2022; 2022():2669114. PubMed ID: 36193167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
    Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
    Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic impact of lncRNAs in acute myeloid leukemia.
    Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of hematopoietic gene expression profiles for prognostic prediction in acute myeloid leukemia.
    Varn FS; Andrews EH; Cheng C
    Sci Rep; 2015 Nov; 5():16987. PubMed ID: 26598031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.